IL31413A - Pharmaceutical compositions containing ethybenzatropine,dihydroergocristine and mesoridazine - Google Patents
Pharmaceutical compositions containing ethybenzatropine,dihydroergocristine and mesoridazineInfo
- Publication number
- IL31413A IL31413A IL31413A IL3141369A IL31413A IL 31413 A IL31413 A IL 31413A IL 31413 A IL31413 A IL 31413A IL 3141369 A IL3141369 A IL 3141369A IL 31413 A IL31413 A IL 31413A
- Authority
- IL
- Israel
- Prior art keywords
- constituent
- dihydroergocristine
- pharmaceutical composition
- mesoridazine
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH64768 | 1968-01-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL31413A0 IL31413A0 (en) | 1969-03-27 |
| IL31413A true IL31413A (en) | 1972-04-27 |
Family
ID=4191874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL31413A IL31413A (en) | 1968-01-16 | 1969-01-14 | Pharmaceutical compositions containing ethybenzatropine,dihydroergocristine and mesoridazine |
Country Status (11)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966923A (en) * | 1972-06-05 | 1976-06-29 | Pierre Fabre S.A. | Medicaments intended for the prevention and treatment of ischemic disturbances |
-
0
- NL NL136837D patent/NL136837C/xx active
-
1968
- 1968-12-23 FR FR179963A patent/FR8107M/fr not_active Expired
- 1968-12-24 NL NL6818657A patent/NL6818657A/xx unknown
- 1968-12-27 SE SE17839/68A patent/SE361598B/xx unknown
-
1969
- 1969-01-07 US US789621A patent/US3629471A/en not_active Expired - Lifetime
- 1969-01-14 AT AT35769A patent/AT305490B/de not_active IP Right Cessation
- 1969-01-14 IL IL31413A patent/IL31413A/en unknown
- 1969-01-14 IE IE53/69A patent/IE32617B1/xx unknown
- 1969-01-14 DE DE19691901496 patent/DE1901496A1/de active Pending
- 1969-01-14 BE BE726861D patent/BE726861A/xx unknown
- 1969-01-15 GB GB2415/69A patent/GB1242315A/en not_active Expired
- 1969-01-15 CA CA040162A patent/CA921827A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE726861A (US08092553-20120110-C00004.png) | 1969-07-14 |
| NL6818657A (US08092553-20120110-C00004.png) | 1969-07-18 |
| GB1242315A (en) | 1971-08-11 |
| IE32617L (en) | 1969-07-16 |
| FR8107M (US08092553-20120110-C00004.png) | 1970-07-27 |
| DE1901496A1 (de) | 1969-08-28 |
| AT305490B (de) | 1973-02-26 |
| IE32617B1 (en) | 1973-10-03 |
| SE361598B (US08092553-20120110-C00004.png) | 1973-11-12 |
| US3629471A (en) | 1971-12-21 |
| IL31413A0 (en) | 1969-03-27 |
| CA921827A (en) | 1973-02-27 |
| NL136837C (US08092553-20120110-C00004.png) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4273774A (en) | Central nervous system compositions and method | |
| AU579028B2 (en) | Anticonvulsant compositions and method | |
| CA1277916C (en) | Pharmaceutical preparations having an antihypertensive and cardio-protective effect | |
| IL31413A (en) | Pharmaceutical compositions containing ethybenzatropine,dihydroergocristine and mesoridazine | |
| US3852453A (en) | Method of enhancing vincamine compositions | |
| JPH0361644B2 (US08092553-20120110-C00004.png) | ||
| DE3525390C2 (US08092553-20120110-C00004.png) | ||
| US3911136A (en) | 1-(O-METHOXY-PHENOXY)-3-ISOPROPYL-AMINO-PROPANE-2-OL HCl and nitroglycerine coronary insufficiency composition | |
| KR100352898B1 (ko) | 새로운3-벤조일-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제 | |
| US3733423A (en) | Hydrogenated ergot alkaloid compositions and methods of using same | |
| Meyer | Oral Administration of Co60 Vitamin B12 in Pernicious Anemia. | |
| GB1600639A (en) | Medicament preparation having resorption properties and method of producing the same | |
| KR890014109A (ko) | 의약제 | |
| CA1139670A (en) | Process and composition for reducing blood pressure in animals | |
| US3795736A (en) | 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1) benzopyrano(3,4-d)pyridine as an analgesic agent | |
| US3108041A (en) | Antitussive compositions | |
| van Rooyen, JM & Offermeier | Peripheral dopaminergic receptors-physiological and pharmaceutical aspects of therapeutic importance | |
| Nies et al. | Recent concepts in the clinical pharmacology of anithypertensive drugs | |
| US3914425A (en) | Antitussive codeine composition | |
| JPH03502802A (ja) | 抗嘔吐性エルゴリン誘導体 | |
| CA1109796A (en) | Process for the production of novel antidiarrheal agents | |
| US3567828A (en) | Organic compounds | |
| US3800041A (en) | Analgesic compositions and methods | |
| US3777028A (en) | 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1)-benzopyrano(3,4-d)pyridine as an anti-diarrheal agent | |
| US4879298A (en) | Novel method and composition |
